Integrative Epidemiology of Cardiovascular diseases

Team Leaders

Jean-Philippe Empana

Team Leader

Xavier Jouven

Team Leader

How to contact ?

Team leaders: Xavier Jouven & Jean-Philippe Empana

Email: xavier.jouven@inserm.fr / jean-philippe.empana@inserm.fr

Phone: +33 1 53 98 79 65 / +33 1 53 98 80 20

Location: 3rd floor

Doctoral school: ED 393 – Public Health: Epidemiology & Biomedical Information Sciences, Université Paris Cité

Objectives & Topics

The main focus of our research is the epidemiology of cardiovascular disease (CVD) at the population level. More specifically, we are addressing the epidemiology of sudden cardiac death, the predictive value of novel biomarkers, the relevance of new preventative strategies such as primordial prevention, and the epidemiological transition towards non-communicable disease (NCDs) in sub-Saharan Africa through a research program on global health. We are coordinating large population-based study cohorts, registries and field studies. We are also strongly anchored in National, European and International research networks including from the global south. This is a 35-staff multidisciplinary team composed of epidemiologists, clinical researchers of different specialties, engineers, assistants permitting to address these different challenges. We are combining classical regression analyses with multidimensional analyses using sophisticated machine learning methods.

Our team is essentially funded by European and National academic grants such as Horizon Europe, COST Action, National Research Agency (ANR), but also by non-profit organizations such as the Medical Research Foundation (FRM), French Society of Cardiology, French Foundation of Cardiology and the Lefoulon-Delalande Foundation.

Projects

1. To develop new approaches to prevent sudden cardiac death (SCD) in the population

Since May 2011, we have established a population-based registry of SCD in the Paris area (Sudden Death Expertise Centre) (https://www.cems-paris.fr/) connecting firefighters, the mobile emergency teams and intensive care units. We therefore collect data in the pre-hospital, intra-hospital and after hospital discharge settings, giving an integrative view of the epidemiology and care of SCD. We have matched these registry data with the unstructured data from the National Health Data Hub to develop an ambitious project using AI techniques to develop and validate algorithms to stratify the risk of SCD in the general population.

2. To study the predictive value of novel biomarkers for CVD

We are currently developing an ambitious and risky project evaluating the predictive value of vascular aging biomarkers measured non-invasively by high-precision carotid echotracking in more than 10,000 participants from the Paris Prospective Study III (https://epp3.org/fr).

In addition to ‘classical’ vascular aging biomarkers, we have started a program on radiomics analyzing the raw signal from the carotid echotracking images. This program is developed in collaboration with researchers from team 3 (P Boutouyrie and RM Bruno). Thanks to its large biobank, we have several ongoing collaborations with PARCC teams on genetics and novel blood biomarkers for CVD.

3. Towards the implementation of primordial prevention

Primordial prevention is a new preventative strategy aiming to prevent the onset of risk factors in the first place to achieve an optimal cardiovascular health (CVH) and ultimately prevent the occurrence of CVD (and beyond). Over the last 10 years, we have conducted several works demonstrating that achieving an optimal CVH was related to substantial risk reduction of CVD in different settings. We have also shown that this benefit went far beyond CVD and concerned the risk of T2D, dementia, depression, cancer, and multimorbidity, permitting to envisage primordial prevention as an integrated preventive approach for multifactorial diseases. We are now moving from research to action and testing the implementation of primordial prevention in different settings and contexts (randomized interventions).

4. Re-thinking global health

The team is engaged both in field studies and in population-based studies, mostly in sub-Saharan Africa. In collaboration with researchers and clinicians from 20 sub-Saharan countries, the African Research Network (ARN, http://www.africa-research.net), under the impulsion of X Jouven (France) and B Diop (Senegal) is conducting fieldwork to address the burden and clinical management of NCDs such as CVD, T2D complications, thalassemia, rheumatic heart diseases, together with the important question of the quality of the medications for these NCDs. Throughout the European University GUILDE alliance, the team is engaged in the Euro Cluster Of Research and Excellence (EURO Core, https://www.the-guild.eu/africa-europe-core/) via a partnership between Université Paris Cité and Université Cheikh Anta Diop. In parallel, through the impulsion of JP Empana, A Nambiema and K Agboyibor, the team is addressing the burden, time trends and determinants of cardio-metabolic and non-cardiometabolic diseases at the population level using sub-Saharan (STEPS) and worldwide (DHS) population-based studies. The team is also engaged in the European University Circle U alliance (https://www.circle-u.eu/) aiming to educate the next European generation on 4 main pillars including Global Health. JP Empana, representing Université Paris Cité, is coordinating the pillar on Global Health. With his co-chairs, they are developing international teaching activities (international summer schools), building international research networks with academic and non-academic stakeholders, and spreading the importance of global health as a research topic towards different stakeholders worldwide. At Université Paris Cité, JP Empana is preparing the launch of an international Master’s degree in Global Health in double recognition with the University of Belgrade with the contribution of the Circle U Universities and its associated partners. All these activities converged to the creation in 2025 of an Institute of Global Health at Université Paris Cité (https://www.santeglobale.paris/). Led by X Jouven, this institute aims to structure global health activities within Université Paris Cité by engaging all the faculties of Université Paris Cité and its associated partners.

Members

Senior clinicians – scientists

Jean-Philippe Empana

Team Leader

Xavier Jouven

Team Leader

Frederic Adnet

Senior clinicians – scientists

Nadia Aissaoui

Senior clinicians – scientists

Marie Antignac

Senior clinicians – scientists

Wulfran Bougouin

Senior clinicians – scientists

Alain Cariou

Senior clinicians – scientists

Richard Chocron

Senior clinicians – scientists

Rachel Climie

Senior clinicians – scientists

Florence Dumas

Senior clinicians – scientists

Guillaume Geri

Senior clinicians – scientists

Patricia Jabre

Senior clinicians – scientists

Daniel Jost

Senior clinicians – scientists

Fabien Picard

Senior clinicians – scientists

Georgios Sideris

Senior clinicians – scientists

Olivier Varenne

Senior clinicians – scientists

Karim Wahbi

Senior clinicians – scientists

Victor Waldman

Senior clinicians – scientists

Early career clinicians – scientists

Kouamivi Agboyibor

Early career clinicians – scientists

Morgane Le Bourvellec

Early career clinicians – scientists

Pauline Cavagna

Early career clinicians – scientists

Emma Menant

Early career clinicians – scientists

Aboubakari Nambiema

Early career clinicians – scientists

Willy Sutter

Early career clinicians – scientists

PhD Students

Oumi Diaby

PhD Students

Maud Koenig

PhD Students

Thomas Laurenceau

PhD Students

Ugo Meli

PhD Students

Vincent Pham

PhD Students

Marie Renaudier

PhD Students

Camila Teixeira Ribeiro

PhD Students

Louise Wang

PhD Students

Public Health internship

Alice Pottier

Public Health internship

Technicians and engineers

Frankie Beganton

Engineer

Halifa Farchati

Integrated Bioinformatics and Biostatistics Platform MANAGER

Marie-Cécile Perier

Engineer

Marjolaine Pernet

Engineer

Brahim Soltana

Engineer

Awards & Fundings

ANR SALVAGE, 2026-2029, coordination Jean-Philippe Empana

This national grant will examine sex and gender disparities in vascular ageing and the differential impact on incident CVD using vascular ageing measurements in 10,000 participants from the Paris Prospective study III. This project is conducted in collaboration with the group of RM Bruno and P Boutouyrie (Team #3) and the team of J Kivits (UP Cité)

FRM Team, 2021-2024, coordination Xavier Jouven.

This project uses artificial intelligence technics to develop and validate risk prediction algorithms for sudden cardiac death in the population using unstructured administrative claims databases.

INSERM International Research Project, 2021-2026, coordination JP Empana.

This grant helps to support and consolidate an international collaboration with the team of Pr C Steehouwer (Maastricht) on the assessment and predictive value of vascular aging parameters for CVD.

Post doc scholarship Lefoulon Delalande, 2025-2027, Aboubakari Nambiema

PhD scholarship Doctoral school 393, 2025-2028, Camila Teixeira Ribeiro (Brazil)

Fondation Coeur Recherche, 2024-26, coordination Jean-Philippe Empana

Using data from the French National health data hub and from the French national forecast stations, the project aims to evaluate the impact of heat temperatures exposure on CVD hospitalizations, the trends and the most vulnerable populations. This is a collaborative project with IRSET (Rennes)

ANR EPIVASCAGE, 2021-2024, coordination Jean-Philippe Empana.

This national grant is currently examining the predictive value of multiple vascular aging parameters for CVD in 10,000 participants from the Paris Prospective study III.

ANR MIMEA, 2022-25, coordination S Taleb (team 5).

In this collaborative project, we will evaluate the predictive value for CVD of the tryptophane and phenyl alanine metabolites as measured by mass spectrometry in the peripheral blood in a case-control study nested within the Paris Prospective study III.

Fédération Française de cardiologie, 2024-2025, coordination H Ait-Oufella (team 5)-JP Empana.

In this collaborative project, we evaluate the predictive value for CVD of upstream immuno-modulators plasma biomarkers throughout the Paris Prospective study III.

COST ACTION VASCAGENET, EU Grant, 2019-23, coordination Austrian Institute of technology, Austria.

This EU grant aimed at creating a European networking of experts and research centres working on vascular ageing.

H2020 ESCAPENET, EU Grant, 2017-22, coordination UMC Amsterdam, The Netherlands.

This grant aimed to study the epidemiology and treatment of cardiac arrest across Europe. It was extended by the COST Action PARQ (see below)

COST ACTION PARQ, EU Grant, 2021-26, coordination by UMC Amsterdam (The Netherlands).

This EU grant aimed at creating a European networking of experts and research centres working on cardiac arrest.

Publications

Laurenceau T, Meli U, Wang LZ, Chocron R, Cezard P, Menant E, Beganton F, Empana JP, Bacry E, Jouven X. Atenolol or Bisoprolol after Myocardial Infarction without Recorded Heart Failure. NEJM Evid. 2026;5(10):EVIDoa2600138.

van Sloten T, Boutouyrie P, Abouqateb M, Bruno RM, Climie RE, Zhu F, Yang S, Farzaneh A, Guedj O, Danchin N, Pannier B, Laurent S, Ikram MK, Mattace-Raso F, Kavousi M, Jouven X, Empana JP. Clusters of vascular aging manifestations predict incident cardiovascular events in the community. Nat Commun. 2026;17(1):3508.

Youssfi Y, Chocron R, Laurenceau T, Beganton F, Empana JP, Rea T, Chopin N, Bougouin W, Jouven X. Machine learning-based prediction of sudden cardiac death in the general population using electronic health record data. Eur J Prev Cardiol. 2026:zwag087.

Agboyibor KM, Nambiema A, Golestani A, Okeibunor J, Diallo CBB, Jouven X, Dangou JM, Farzadfar F, Empana JP; African STEPS Group. Prevalence, time trends and associated factors of adult overweight and obesity in 36 countries in the WHO African region from 2003 to 2022: a study of 54 WHO STEPS surveys representing 156 million adults. BMJ Glob Health. 2026;11(1):e019988.

Agboyibor KM, Nambiema A, Gbeasor F, Barengo N, Okeibunor JC, Jouven X, Dangou JM, Farzadfar F, Empana JP. Prevalence, Determinants, and Time Trends of Cardiovascular Health in the WHO African Region. JAMA Cardiol. 2025:e253377.

Antignac M, N’Guetta R, Secretan PH, Do B, Ikama MS, Mipinda JB, Toure IA, Takombe JL, Lubenga Y, Dia MM, Isselmou Boukhary Ould EB, Dalaba M, Balde NM, Kake A, Sy ECI, Cavagna P, Perier MC, Sobngwi E, Cisse PB, Boitard C, Empana JP, Diop IB, Mbaye MN, Jouven X. Quality of antidiabetic medicines in 13 sub-Saharan African countries: a cross-sectional survey. EClinicalMedicine. 2025;87:103405.

Prugger C, Perier MC, Sabia S, Fayosse A, van Sloten T, Jouven X, Pentti J, Kivimäki M, Empana JP. Association between changes in cardiovascular health and the risk of multimorbidity: community-based cohort studies in the UK and Finland. Lancet Reg Health Eur. 2024;42:100922.

Nambiema A, Lisan Q, Vaucher J, Perier MC, Boutouyrie P, Danchin N, Thomas F, Guibout C, Solelhac G, Heinzer R, Jouven X, Marques-Vidal P, Empana JP. Healthy sleep score changes and incident cardiovascular disease in European prospective community-based cohorts. Eur Heart J. 2023;44:4968-4978.

van Sloten TT, Valentin E, Climie RE, Jouven X, Lemogne C, Goldberg M, Zins M, Empana JP. Association of Cardiovascular Health With Risk of Clinically Relevant Depressive Symptoms. JAMA Psychiatry. 2023;80:342-349.

Michelland L, Murad MH, Bougouin W, Van Der Broek M, Prokop LJ, Anys S, Perier MC, Cariou A, Empana JP, Marijon E, Jouven X, Jabre P. Association between basic life support and survival in sports-related sudden cardiac arrest: a meta-analysis. Eur Heart J. 2023;44:180-192.

Empana JP, Lerner I, Valentin E, Folke F, Böttiger B, Gislason G, Jonsson M, Ringh M, Beganton F, Bougouin W, Marijon E, Blom M, Tan H, Jouven X; ESCAPE-NET Investigators. Incidence of Sudden Cardiac Death in the European Union. J Am Coll Cardiol. 2022;79:1818-1827.

Loupy A, Coutance G, Bonnet G, Van Keer J, Raynaud M, Aubert O, Bories MC, Racapé M, Yoo D, Duong Van Huyen JP, Bruneval P, Taupin JL, Lefaucheur C, Varnous S, Leprince P, Guillemain R, Empana JP, Levine R, Naesens M, Patel JK, Jouven X, Kobashigawa J. Identification and Characterization of Trajectories of Cardiac Allograft Vasculopathy After Heart Transplantation: A Population-Based Study. Circulation. 2020;141:1954-1967.

Gaye B, Khoury S, Cene CW, Kingue S, N’Guetta R, Lassale C, Baldé D, Diop IB, Dowd JB, Mills MC, Jouven X. Socio-demographic and epidemiological consideration of Africa’s COVID-19 response: what is the possible pandemic course? Nat Med. 2020;26:996-999.

Loupy A, Aubert O, Orandi BJ, Naesens M, Bouatou Y, Raynaud M, Divard G, Jackson AM, Viglietti D, Giral M, Kamar N, Thaunat O, Morelon E, Delahousse M, Kuypers D, Hertig A, Rondeau E, Bailly E, Eskandary F, Böhmig G, Gupta G, Glotz D, Legendre C, Montgomery RA, Stegall MD, Empana JP, Jouven X, Segev DL, Lefaucheur C. Prediction system for risk of allograft loss in patients receiving kidney transplants: international derivation and validation study. BMJ. 2019;366:l4923.

Samieri C, Perier MC, Gaye B, Proust-Lima C, Helmer C, Dartigues JF, Berr C, Tzourio C, Empana JP. Association of Cardiovascular Health Level in Older Age With Cognitive Decline and Incident Dementia. JAMA. 2018;320:657-664.

van Sloten TT, Tafflet M, Périer MC, Dugravot A, Climie RE, Singh-Manoux A, Empana JP. Association of Change in Cardiovascular Risk Factors With Incident Cardiovascular Events. JAMA. 2018;320:1793-1804.

Sharman JE, Boutouyrie P, Perier MC, Thomas F, Guibout C, Khettab H, Pannier B, Laurent S, Jouven X, Empana JP. Impaired baroreflex sensitivity, carotid stiffness, and exaggerated exercise blood pressure: a community-based analysis from the Paris Prospective Study III. Eur Heart J. 2018;39:599-606.

Loupy A, Duong Van Huyen JP, Hidalgo L, Reeve J, Racapé M, Aubert O, Venner JM, Falmuski K, Bories MC, Beuscart T, Guillemain R, François A, Pattier S, Toquet C, Gay A, Rouvier P, Varnous S, Leprince P, Empana JP, Lefaucheur C, Bruneval P, Jouven X, Halloran PF. Gene Expression Profiling for the Identification and Classification of Antibody-Mediated Heart Rejection. Circulation. 2017;135:917-935.

Ranque B, Menet A, Boutouyrie P, Diop IB, Kingue S, Diarra M, N’Guetta R, Diallo D, Diop S, Diagne I, Sanogo I, Tolo A, Chelo D, Wamba G, Gonzalez JP, Abough’elie C, Diakite CO, Traore Y, Leugeun G, Deme-Ly I, Faye BF, Seck M, Kouakou B, Kamara I, Le Jeune S, Jouven X. Arterial Stiffness Impairment in Sickle Cell Disease Associated with Chronic Vascular Complications: The Multinational African CADRE Study. Circulation. 2016;134:923-33.

Marijon E, Bougouin W, Tafflet M, Karam N, Jost D, Lamhaut L, Beganton F, Pelloux P, Degrange H, Beal G, Tourtier JP, Hagege AA, Le Heuzey JY, Desnos M, Dumas F, Spaulding C, Celermajer DS, Cariou A, Jouven X. Population Movement and Sudden Cardiac Arrest Location. Circulation. 2015;131:1546-54.

Lefaucheur C*, Loupy A*, Vernerey D, Duong-Van-Huyen JP, Suberbielle C, Anglicheau D, Vérine J, Beuscart T, Nochy D, Bruneval P, Charron D, Delahousse M, Empana JP, Hill GS, Glotz D, Legendre C, Jouven X. Antibody-mediated vascular rejection of kidney allografts: a population-based study. Lancet. 2013;381:313-9.

Loupy A, Lefaucheur C, Vernerey D, Prugger C, Duong van Huyen JP, Mooney N, Suberbielle C, Frémeaux-Bacchi V, Méjean A, Desgrandchamps F, Anglicheau D, Nochy D, Charron D, Empana JP, Delahousse M, Legendre C, Glotz D, Hill GS, Zeevi A, Jouven X. Complement-Binding Anti-HLA Antibodies and Kidney-Allograft Survival. N Engl J Med. 2013;369:1215-1226.

Jabre P, Belpomme V, Azoulay E, Jacob L, Bertrand L, Lapostolle F, Tazarourte K, Bouilleau G, Pinaud V, Broche C, Normand D, Baubet T, Ricard-Hibon A, Istria J, Beltramini A, Alheritiere A, Assez N, Nace L, Vivien B, Turi L, Launay S, Desmaizieres M, Borron SW, Vicaut E, Adnet F. Family presence during cardiopulmonary resuscitation. N Engl J Med. 2013;368:1008-18.

Jouven X, Empana JP, Schwartz PJ, Desnos M, Courbon D, Ducimetière P. Heart-rate profile during exercise as a predictor of sudden death. N Engl J Med. 2005;352:1951-8.

Empana JP, Sykes DH, Luc G, Juhan-Vague I, Arveiler D, Ferrieres J, Amouyel P, Bingham A, Montaye M, Ruidavets JB, Haas B, Evans A, Jouven X, Ducimetiere P; PRIME Study Group. Contributions of depressive mood and circulating inflammatory markers to coronary heart disease in healthy European men: the Prospective Epidemiological Study of Myocardial Infarction (PRIME). Circulation. 2005;111:2299-305.

Empana JP, Ducimetiere P, Charles MA, Jouven X. Sagittal abdominal diameter and risk of sudden death in asymptomatic middle-aged men: the Paris Prospective Study I. Circulation. 2004;110:2781-5.

Jouven X, Zureik M, Desnos M, Courbon D, Ducimetière P. Long-term outcome in asymptomatic men with exercise-induced premature ventricular depolarizations. N Engl J Med. 2000;343:826-33.

Balkau B, Jouven X, Ducimetière P, Eschwège E. Diabetes as a risk factor for sudden death. Lancet. 1999;354:1968-9.

Jouven X, Desnos M, Guerot C, Ducimetière P. Predicting sudden death in the population: the Paris Prospective Study I. Circulation. 1999;99:1978-83.